WatchGov

Virginia bills · 2026 Regular Session

Virginia HB 800

Active Pharmaceutical Ingredient Manufacturing Grant Fund; established.

  1. Introduced
  2. In committee
  3. Passed House
  4. Passed Senate
  5. To Governor
  6. Became law

Sponsors

Cosponsors (1)

Summary

Official abstract published by the Virginia legislature· SUMMARY AS PASSED

Active Pharmaceutical Ingredient Manufacturing Grant Fund. Establishes the Active Pharmaceutical Ingredient Manufacturing Grant Fund to provide grant installment awards between July 1, 2026, and July 1, 2045, in an amount not to exceed $15 million per fiscal year and in an aggregate amount not to exceed $130 million, to a qualified company that (i) engages in the manufacture of pharmaceutical substances, (ii) executes a memorandum of understanding with the Commonwealth, and (iii) is expected to make a capital investment of at least $2,148,793,019 and create and maintain at least 468 new full-time jobs. This bill is identical to SB 404.

Text versions

Roll-call votes

State vote data last updated Oct 15, 2026, 8:06 AM.

DateVoteResultYour legislators
Feb 19, 2026
Senate		Passage RpassSet your home in Virginia to see
Feb 18, 2026
Senate		Constitutional reading dispensed (on 2nd reading)passSet your home in Virginia to see
Feb 17, 2026
Senate		Reported from Finance and AppropriationspassSet your home in Virginia to see
Feb 5, 2026
House		H VOTE:passSet your home in Virginia to see
Jan 30, 2026
House		Reported from AppropriationspassSet your home in Virginia to see
Jan 28, 2026
House		Subcommittee recommends reportingpassSet your home in Virginia to see

Actions